Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune System Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchStudy completedNCT01672255
What this trial is testing

Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes Mellitus (DM)

Who this might be right for
Type 1 DiabetesHypoglycemia Associated Autonomic Failure
University of Maryland, Baltimore 64
Testing effectiveness (Phase 2)Ended earlyNCT02075008
What this trial is testing

Long-term Safety Study of QGE031 in Patients With Allergic Asthma Who Completed Study CQGE031B2201

Who this might be right for
Asthma
Novartis Pharmaceuticals 270
Early research (Phase 1)UnknownNCT03840317
What this trial is testing

Senl_1904A and Senl_1904B Chimeric Antigen Receptor （CAR） T-Cell in the Treatment of r/ r Acute B Lymphocytic Leukemia

Who this might be right for
Acute Lymphocytic Leukemia
Hebei Senlang Biotechnology Inc., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT01865617
What this trial is testing

Laboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic Leukemia

Who this might be right for
CD19-Positive Neoplastic Cells PresentRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+10 more
Fred Hutchinson Cancer Center 204
Large-scale testing (Phase 3)Study completedNCT00002140
What this trial is testing

A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
Pfizer
Early research (Phase 1)Study completedNCT03907540
What this trial is testing

Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025

Who this might be right for
Autoimmune DiseasesFibrosis
Kadmon Corporation, LLC 5
Early research (Phase 1)Study completedNCT05114889
What this trial is testing

Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Biosion, Inc. 54
Not applicableLooking for participantsNCT05767450
What this trial is testing

Intervention on New Onset-T1D Children

Who this might be right for
Type 1 Diabetes
IRCCS San Raffaele 60
Not applicableStudy completedNCT00000950
What this trial is testing

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Not applicableLooking for participantsNCT06169150
What this trial is testing

Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity

Who this might be right for
Nervous System DiseaseImmune System Disease
National Institute of Allergy and Infectious Diseases (NIAID) 350
Not applicableUnknownNCT03721991
What this trial is testing

GABA Treatment in Subjects With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
Steno Diabetes Center Copenhagen 30
Post-approval studies (Phase 4)Study completedNCT00518518
What this trial is testing

Safety and Efficacy of Ultra-Rush Sublingual Immunotherapy in Children With Asthma Allergic to Grass Pollen

Who this might be right for
Asthma
Medical University of Lodz 50
Not applicableEnded earlyNCT00513318
What this trial is testing

Pilot Study of Reduced-Intensity Umbilical Cord Blood Transplantation in Adult Patients Wtih Advanced Hematopoietic Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplasiaAcute Lymphoblastic Leukemia+4 more
University of California, San Francisco 15
Not applicableStudy completedNCT03878810
What this trial is testing

Exergaming in Persons With Multiple Sclerosis With Restless Legs Syndrome

Who this might be right for
Multiple Sclerosis
Dokuz Eylul University 65
Testing effectiveness (Phase 2)UnknownNCT01016990
What this trial is testing

Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Auxilio Mutuo Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT01788813
What this trial is testing

To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies

Who this might be right for
Mild Asthma and Allergic Rhinitis
GlaxoSmithKline 42
Large-scale testing (Phase 3)Active Not RecruitingNCT03984448
What this trial is testing

Testing the Addition of a New Anti-cancer Drug, Venetoclax, to Usual Chemotherapy for High Grade B-cell Lymphomas

Who this might be right for
Diffuse Large B-Cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedDouble-Expressor Lymphoma+5 more
National Cancer Institute (NCI) 363
Not applicableStudy completedNCT04477655
What this trial is testing

Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure

Who this might be right for
Covid19
Hospital Civil de Guadalajara 430
Testing effectiveness (Phase 2)Study completedNCT04014335
What this trial is testing

Evaluate the Effectiveness and Safety of IONIS-FB-LRx, an Antisense Inhibitor of Complement Factor B, in Adult Participants With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Ionis Pharmaceuticals, Inc. 23
Large-scale testing (Phase 3)Study completedNCT00457015
What this trial is testing

Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 96
Next Page